Authors:
VIALETTES BH
PAQUISFLUCKLINGER V
PELISSIER JF
BENDAHAN D
NARBONNE H
SILVESTREAILLAUD P
MONTFORT MF
RIGHINICHOSSEGROS M
POUGET J
COZZONE PJ
DESNUELLE C
Citation: Bh. Vialettes et al., PHENOTYPIC-EXPRESSION OF DIABETES SECONDARY TO A T14709C MUTATION OF MITOCHONDRIAL-DNA - COMPARISON WITH MIDD SYNDROME (A3243G MUTATION) - A CASE-REPORT, Diabetes care, 20(11), 1997, pp. 1731-1737
Authors:
VIALETTES B
NARBONNE H
PAQUISFLUCKLINGER V
BENDAHAN D
PELISSIER JF
MONFORT MF
SILVESTREAILLAUD P
DESNUELLE C
Citation: B. Vialettes et al., PREVALENCE OF BLOOD AND MUSCLE MT DNA ANOMALY IN A HIGHLY SELECTED DIABETIC POPULATION AT RISK OF MITOCHONDRIAL CYTOPATHY, Diabetologia, 40, 1997, pp. 661-661
Authors:
VIALETTES B
PAQUISFLUCKINGER V
SILVESTREAILLAUD P
PELISSIER JF
NARBONNE H
BENDAHAN D
COZZONE P
DESNUELLE C
Citation: B. Vialettes et al., FAMILIAL DIABETES SECONDARY TO A NOVEL-POINT-MUTATION(14709) OF MT-DNA IN THE REGION CODING FOR TRNA(GLU), Diabetologia, 39, 1996, pp. 13-13
Authors:
VIALETTES B
PAQUISFLUCKINGER V
SILVESTREAILLAUD P
BENDAHAN D
PELISSIER JF
ETCHARYBOUYX F
RACCAH D
GIN H
GUILLAUSSEAU PJ
VANUXEN D
ORSINI F
POUGET J
COZZONE P
DESNUELLE C
Citation: B. Vialettes et al., EXTRA-PANCREATIC MANIFESTATIONS IN DIABETES SECONDARY TO MITOCHONDRIAL-DNA POINT MUTATION WITHIN THE TRNA(LEU(UUR)) GENE, Diabetes care, 18(7), 1995, pp. 1023-1028
Authors:
SILVESTREAILLAUD P
BENDAHAN D
PAQUISFLUCKINGER V
POUGET J
PELISSIER JF
DESNUELLE C
COZZONE PJ
VIALLETTES B
Citation: P. Silvestreaillaud et al., COULD COENZYME-Q10 AND L-CARNITINE BE A TREATMENT FOR DIABETES SECONDARY TO 3243 MUTATION OF MTDNA, Diabetologia, 38(12), 1995, pp. 1485-1486